Pay in 4 interest-free payments of $5.00 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
With our expert team and holistic approach, we help you achieve optimal health and unlock your full potential
Phase I study of the indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor navoximod (GDC-0919) administered with PD-L1 inhibitor (Atezolizumab) in advanced solid tumors
Additionally, the company ships internationally at a flat rate of $12.95
Research from Hokkaido University published in Cell Metabolism showed NNMT enzyme activity suppression peaked at specific tissue concentrations
US$ 25.31
US$ 20.13
US$ 20.83
US$ 29.40
US$ 23.39
US$ 25.70
